Etienne Adriansen
Corporate Officer/Principal chez CERENO SCIENTIFIC AB
Profil
Etienne Adriansen is currently the Chief Business Officer at Cereno Scientific AB since 2023.
Prior to this, he worked as the Deputy Director at Healthcare Denmark from 2018 to 2021, and as the Head of Global Business Development at LEO Pharma.
A from 2015 to 2018.
From 2003 to 2011, he worked at Takeda A as the Director of Strategic Planning & Business Development.
He also worked as the Head of Business Development at Cessatech A.
Mr. Adriansen received his undergraduate degree in 1988 and his graduate degree in 1987 from the University of Aarhus.
Postes actifs de Etienne Adriansen
| Sociétés | Poste | Début |
|---|---|---|
| CERENO SCIENTIFIC AB | Corporate Officer/Principal | 01/01/2023 |
Anciens postes connus de Etienne Adriansen
| Sociétés | Poste | Fin |
|---|---|---|
| CESSATECH A/S | Corporate Officer/Principal | 01/02/2023 |
Healthcare Denmark
 Healthcare Denmark Medical/Nursing ServicesHealth Services Healthcare Denmark is a non-profit public-private partnership that promotes expertise and innovation in Danish healthcare and life science. The non-profit company is based in Odense, Denmark. The Danish company offers networking and other services to support these goals. The company was founded in 2012, and Jakob Skaarup Nielsen has been the CEO of the company since 2021. | Corporate Officer/Principal | 01/08/2021 |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | 01/09/2018 |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Corporate Officer/Principal | 01/08/2011 |
Formation de Etienne Adriansen
| University of Aarhus | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CERENO SCIENTIFIC AB | Health Technology |
| CESSATECH A/S | Health Technology |
| Entreprise privées | 3 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Finance |
Healthcare Denmark
Healthcare Denmark Medical/Nursing ServicesHealth Services Healthcare Denmark is a non-profit public-private partnership that promotes expertise and innovation in Danish healthcare and life science. The non-profit company is based in Odense, Denmark. The Danish company offers networking and other services to support these goals. The company was founded in 2012, and Jakob Skaarup Nielsen has been the CEO of the company since 2021. | Health Services |
